{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:05:07Z","timestamp":1793160307916,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,7]]},"abstract":"<jats:p>Kanack and colleagues analyze anti-platelet factor 4 antibodies from 5 patients with vaccine-induced thrombotic thrombocytopenia (VITT) secondary to COVID-19 adenoviral vaccination and antibodies from patients with spontaneous heparin-induced thrombocytopenia (HIT) and classical HIT. VITT antibodies are monoclonal or oligoclonal, similar to spontaneous HIT, whereas classical HIT antibodies are polyclonal. Heparin inhibits antibody-induced platelet activation in VITT, suggesting that heparin should be considered for the treatment of VITT.<\/jats:p>","DOI":"10.1182\/blood.2021014588","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T13:02:43Z","timestamp":1652446963000},"page":"73-77","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":71,"title":["Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT"],"prefix":"10.1182","volume":"140","author":[{"given":"Adam J.","family":"Kanack","sequence":"first","affiliation":[{"name":"1Department of\u00a0Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Bayas","sequence":"additional","affiliation":[{"name":"2Department of Neurology and Clinical Neurophysiology, University Hospital of Augsburg, Augsburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemlyn","family":"George","sequence":"additional","affiliation":[{"name":"3Department of Medicine, University of Colorado, Aurora, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-4366","authenticated-orcid":false,"given":"Mouhamed Yazan","family":"Abou-Ismail","sequence":"additional","affiliation":[{"name":"4Department of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandana","family":"Singh","sequence":"additional","affiliation":[{"name":"1Department of\u00a0Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy C.","family":"Kohlhagen","sequence":"additional","affiliation":[{"name":"1Department of\u00a0Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah P.","family":"Splinter","sequence":"additional","affiliation":[{"name":"1Department of\u00a0Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Christ","sequence":"additional","affiliation":[{"name":"2Department of Neurology and Clinical Neurophysiology, University Hospital of Augsburg, Augsburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Naumann","sequence":"additional","affiliation":[{"name":"2Department of Neurology and Clinical Neurophysiology, University Hospital of Augsburg, Augsburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Moser","sequence":"additional","affiliation":[{"name":"5Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT;"},{"name":"6ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-6461","authenticated-orcid":false,"given":"Kristi J.","family":"Smock","sequence":"additional","affiliation":[{"name":"5Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT;"},{"name":"6ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Grazioli","sequence":"additional","affiliation":[{"name":"7National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD;"},{"name":"8Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-8212","authenticated-orcid":false,"given":"Renren","family":"Wen","sequence":"additional","affiliation":[{"name":"9Blood Research Institute, Versiti, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demin","family":"Wang","sequence":"additional","affiliation":[{"name":"9Blood Research Institute, Versiti, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Murray","sequence":"additional","affiliation":[{"name":"1Department of\u00a0Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-4377","authenticated-orcid":false,"given":"Anand","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"1Department of\u00a0Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"13","key":"2022070715214902500_B1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.2021.3199","article-title":"SARS-CoV-2 vaccines","volume":"325","author":"Creech","year":"2021","journal-title":"JAMA."},{"issue":"22","key":"2022070715214902500_B2","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med."},{"issue":"22","key":"2022070715214902500_B3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"issue":"23","key":"2022070715214902500_B4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med."},{"issue":"20","key":"2022070715214902500_B5","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N Engl J Med."},{"issue":"4","key":"2022070715214902500_B6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M21-4502","article-title":"Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination-United States, December 2020 to August 2021","volume":"175","author":"See","year":"2022","journal-title":"Ann Intern Med."},{"issue":"9","key":"2022070715214902500_B7","doi-asserted-by":"crossref","first-page":"E346","DOI":"10.1002\/ajh.26265","article-title":"Vaccine-induced thrombotic thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous thromboembolism","volume":"96","author":"Abou-Ismail","year":"2021","journal-title":"Am J Hematol."},{"issue":"8","key":"2022070715214902500_B8","doi-asserted-by":"crossref","first-page":"E301","DOI":"10.1002\/ajh.26237","article-title":"Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination","volume":"96","author":"George","year":"2021","journal-title":"Am J Hematol."},{"issue":"10285","key":"2022070715214902500_B9","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet."},{"issue":"8","key":"2022070715214902500_B10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med."},{"issue":"4","key":"2022070715214902500_B11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood."},{"issue":"5","key":"2022070715214902500_B12","doi-asserted-by":"crossref","first-page":"e12529","DOI":"10.1002\/rth2.12529","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"issue":"18","key":"2022070715214902500_B13","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med."},{"key":"2022070715214902500_B14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijlh.12993","article-title":"Laboratory diagnosis of heparin-induced thrombocytopenia","volume":"41","author":"Warkentin","year":"2019","journal-title":"Int J Lab Hematol."},{"issue":"3","key":"2022070715214902500_B15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/trf.15105","article-title":"Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia","volume":"59","author":"Irani","year":"2019","journal-title":"Transfusion."},{"issue":"2","key":"2022070715214902500_B16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41408-021-00408-4","article-title":"Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report","volume":"11","author":"Murray","year":"2021","journal-title":"Blood Cancer J."},{"issue":"2","key":"2022070715214902500_B17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cll.2021.03.003","article-title":"Clinical mass spectrometry approaches to myeloma and amyloidosis","volume":"41","author":"Murray","year":"2021","journal-title":"Clin Lab Med."},{"issue":"4","key":"2022070715214902500_B18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood."},{"issue":"2","key":"2022070715214902500_B19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jth.14369","article-title":"Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia","volume":"17","author":"Huynh","year":"2019","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022070715214902500_B20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bjh.14603","article-title":"The unique immunological features of heparin-induced thrombocytopenia","volume":"177","author":"Staibano","year":"2017","journal-title":"Br J Haematol."},{"issue":"2","key":"2022070715214902500_B21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V89.2.370","article-title":"Fc gamma RIIA H\/R 131 polymorphism, subclass-specific IgG anti-heparin\/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis","volume":"89","author":"Arepally","year":"1997","journal-title":"Blood."},{"issue":"17","key":"2022070715214902500_B22","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med."},{"issue":"5","key":"2022070715214902500_B23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajh.26488","article-title":"Persistence of Ad26.COV2. S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol."},{"issue":"12","key":"2022070715214902500_B24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2021014214","article-title":"Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient","volume":"139","author":"Sch\u00f6nborn","year":"2022","journal-title":"Blood."},{"issue":"7873","key":"2022070715214902500_B25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/1\/73\/1905419\/bloodbld2021014588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/1\/73\/1905419\/bloodbld2021014588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T11:22:20Z","timestamp":1657192940000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/1\/73\/485235\/Monoclonal-and-oligoclonal-anti-platelet-factor-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014588","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742139966.793594162","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.23.21263047","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}